These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10568064)

  • 41. [A clinical trial of a monophasic contraceptive preparation containing ethinyl estradiol and desogestrel].
    Bilotta P; Favilli S
    Akush Ginekol (Mosk); 1992; (8-12):40-3. PubMed ID: 1292360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
    Thorneycroft lH; Gollnick H; Schellschmidt I
    Cutis; 2004 Aug; 74(2):123-30. PubMed ID: 15379365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multi-centre open study of a triphasic levonorgestrel-ethinyloestradiol combined oral contraceptive ('Trinordiol').
    Butler AJ; Green A; Cohen M
    Curr Med Res Opin; 1987; 10(8):503-13. PubMed ID: 2960493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
    Kaunitz AM; Archer DF; Mishell DR; Foegh M
    Am J Obstet Gynecol; 2015 Mar; 212(3):318.e1-8. PubMed ID: 25220709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Less estrogen in new oral contraceptive.
    Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.
    Bachmann G; Sulak PJ; Sampson-Landers C; Benda N; Marr J
    Contraception; 2004 Sep; 70(3):191-8. PubMed ID: 15325887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
    Moggia AV
    J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
    Dieben TO; op ten Berg MT; Coelingh Bennink HJ
    Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral contraception, 1986. Focus on Triphasil.
    Ellsworth H
    J Reprod Med; 1986 Jun; 31(6 Suppl):559-64. PubMed ID: 3522896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.
    LaGuardia KD; Shangold G; Fisher A; Friedman A; Kafrissen M
    Contraception; 2003 Jun; 67(6):431-7. PubMed ID: 12814811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Combined hormonal contraception in cycles artificially extended].
    Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
    Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP; Mathias A
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A triphasic oral contraceptive pill, CTR-05: clinical efficacy and safety.
    Singh M; Thomas D; Singh R; Saxena BB; Ledger WJ
    Eur J Contracept Reprod Health Care; 1996 Sep; 1(3):285-92. PubMed ID: 9678128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Large observational trial of a new low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 100 micrograms levonorgestrel (Miranova) in Germany.
    Hite RC; Bannemerschult R; Fox-Kuchenbecker P; Turck R; Brill K
    Eur J Contracept Reprod Health Care; 1999 Mar; 4(1):7-13. PubMed ID: 10367190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose ethinylestradiol/levonorgestrel.
    Dando TM; Curran MP
    Drugs; 2005; 65(16):2299-306; discusion 2307-8. PubMed ID: 16266199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The effectiveness and acceptability of oral contraceptives (Logest), containing 20 micrograms ethinylestradiol and 75 micrograms gestodene].
    Lech MM; Swiatek EJ
    Ginekol Pol; 2004 Mar; 75(3):209-14. PubMed ID: 15181879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of an oral contraceptive containing chlormadinone and ethinylestradiol on acne-prone skin of women of different age groups: an open-label, single-centre, phase IV study.
    Kerscher M; Reuther T; Bayrhammer J; Schramm G
    Clin Drug Investig; 2008; 28(11):703-11. PubMed ID: 18840013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene in Latin American women.
    Bassol S; Alvarado G; Arreola RG; Celis-Gonzalez C; Peña EP; Flores JG; Ahued JR; Ricalde RL; Lopez CR; Prieto G; Gurucharri C; Heredia MG; Ortiz OC; Percossi G; Figueroa Casas PR; Botto E; Tozzini RI; Botti G; Nuñez de Pierro A; Fernandez M; Lastreto E; Nañez M; Carneiro de Oliveira H; Diogenes Holanda Yazlle ME; Silva J; Salazar G; Gomez J; Penagos G; Cifuentes R; Torres LA; Reyes-Marquez R; Albrecht G
    Contraception; 2003 May; 67(5):367-72. PubMed ID: 12742559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.